Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 86Neoplasm Metastasis 75Colorectal Neoplasms 74Neoplasms 70Leukemia, Myeloid, Acute 61Breast Neoplasms 57Multiple Myeloma 48Prostatic Neoplasms 47Ovarian Neoplasms 44Squamous Cell Carcinoma of Head and Neck 39Pancreatic Neoplasms 39Melanoma 36Recurrence 34Triple Negative Breast Neoplasms 31Lymphoma, Non-Hodgkin 31Lung Neoplasms 31Glioblastoma 30Myelodysplastic Syndromes 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Endometrial Neoplasms 27Advanced Solid Tumors 27Stomach Neoplasms 25Carcinoma, Renal Cell 25Small Cell Lung Carcinoma 24Sarcoma 23Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 19Esophageal Neoplasms 19Lymphoma, B-Cell 17

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × B-cell Malignancies × 30 days × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡